α-Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism

Affiliations

¹ Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
² 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
³ The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Quebec, Canada.
⁴ Department of Neurology and neurosurgery, McGill University, Montréal, Quebec, Canada.
⁵ Department of Human Genetics, McGill University, Montréal, Quebec, Canada.
⁶ Medical School, University of Cyprus, Nicosia, Cyprus.
⁷ Department of Neurology, Medical School, University of Crete, Heraklion, Greece.
⁸ Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
⁹ Nuclear Medicine Laboratory, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

Comment

Maria Sokratous et al. Mov Disord. 2021 Sep.

. 2021 Sep;36(9):2209-2212.

doi: 10.1002/mds.28735.

¹ Department of Neurology, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
² 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
³ The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montréal, Quebec, Canada.
⁴ Department of Neurology and neurosurgery, McGill University, Montréal, Quebec, Canada.
⁵ Department of Human Genetics, McGill University, Montréal, Quebec, Canada.
⁶ Medical School, University of Cyprus, Nicosia, Cyprus.
⁷ Department of Neurology, Medical School, University of Crete, Heraklion, Greece.
⁸ Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
⁹ Nuclear Medicine Laboratory, University Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.

No abstract available

Comment in

Reply to: "α-Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism".
Liu H, Koros C, Stefanis L, Gasser T. Liu H, et al. Mov Disord. 2021 Sep;36(9):2212-2213. doi: 10.1002/mds.28742. Mov Disord. 2021. PMID: 34543467 No abstract available.

A Novel SNCA A30G Mutation Causes Familial Parkinson's Disease.
Liu H, Koros C, Strohäker T, Schulte C, Bozi M, Varvaresos S, Ibáñez de Opakua A, Simitsi AM, Bougea A, Voumvourakis K, Maniati M, Papageorgiou SG, Hauser AK, Becker S, Zweckstetter M, Stefanis L, Gasser T. Liu H, et al. Mov Disord. 2021 Jul;36(7):1624-1633. doi: 10.1002/mds.28534. Epub 2021 Feb 22. Mov Disord. 2021. PMID: 33617693

1. Gasser T, Hardy J, Mizuno Y. Milestones in PD genetics. Mov Disord 2011;26:1042-1048.
1. Liu H, Koros C, Strohäker T, et al. A novel SNCA A30G mutation causes familial Parkinsonʼs disease. Mov. Disord. 2021;36:1-11. https://doi.org/10.1002/mds.28534
1. Martin LJ, Pan Y, Price AC, et al. Parkinson's disease α-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 2006;26:41-50.
1. Poon HF, Frasier M, Shreve N, et al. Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice - a model of familial Parkinson's disease. Neurobiol Dis 2005;18:492-498.
1. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 2008;283:9089-9100.